Pyramid Biosciences

About:

Pyramid Biosciences is a provider of biotechnological services.

Website: https://pyramidbio.com

Top Investors: Adage Capital Management, Alpine Meridian, Prospect Hill Growth Partners, Oracle Investment Management Inc., Boston Harbor Angels

Description:

Pyramid Biosciences is dedicated to discovering and developing targeted therapeutics for a wide range of disorders that are regulated by the tropomyosin receptor kinase (TRK) family. By precisely and selectively modulating the actions of these fundamental cell surface receptors, we can control the key signaling pathways responsible for a patient’s disease, condition, or symptoms.

Total Funding Amount:

$61.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Needham, Massachusetts, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)pyramidbio.com

Founders:

Jordan Leef, Kollol Pal

Number of Employees:

1-10

Last Funding Date:

2021-10-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai